X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15) 15
oncology (15) 15
middle aged (14) 14
aged (13) 13
female (13) 13
adult (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
male (9) 9
13-cis retinoic acid (7) 7
treatment outcome (7) 7
cisplatin (6) 6
interleukin-2 (6) 6
maintenance therapy (6) 6
aged, 80 and over (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
cancer (5) 5
chemotherapy (5) 5
renal-cell carcinoma (5) 5
survival (5) 5
capecitabine (4) 4
carcinoma (4) 4
deoxycytidine - administration & dosage (4) 4
deoxycytidine - analogs & derivatives (4) 4
paclitaxel (4) 4
randomized-trial (4) 4
survival analysis (4) 4
therapy (4) 4
13-cis-retinoic acid (3) 3
antitumor-activity (3) 3
breast cancer (3) 3
disease-free survival (3) 3
fluorouracil - administration & dosage (3) 3
fluorouracil - analogs & derivatives (3) 3
gemcitabine (3) 3
high-dose interleukin-2 (3) 3
immunology (3) 3
immunotherapy (3) 3
interleukin-2 - therapeutic use (3) 3
killer cells, natural - drug effects (3) 3
killer cells, natural - immunology (3) 3
lymphocyte count (3) 3
ovarian neoplasms - drug therapy (3) 3
oxaliplatin (3) 3
prognostic factors (3) 3
regulatory t-cells (3) 3
research (3) 3
time factors (3) 3
vascular endothelial growth factor a - metabolism (3) 3
5-fluorouracil (2) 2
antimetabolites, antineoplastic - administration & dosage (2) 2
antineoplastic agents - therapeutic use (2) 2
breast neoplasms - drug therapy (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
care and treatment (2) 2
cd4-cd8 ratio (2) 2
clinical-trials (2) 2
cohort studies (2) 2
cyclophosphamide (2) 2
design affects outcomes (2) 2
disease progression (2) 2
docetaxel (2) 2
dose-response relationship, drug (2) 2
doxorubicin - administration & dosage (2) 2
ifosfamide (2) 2
immunotherapy - methods (2) 2
interferon alpha-2a (2) 2
interleukin-2 - administration & dosage (2) 2
interleukin-2 - adverse effects (2) 2
isotretinoin - administration & dosage (2) 2
isotretinoin - adverse effects (2) 2
isotretinoin - therapeutic use (2) 2
leucovorin (2) 2
medicine, research & experimental (2) 2
metastasis (2) 2
neoplasm metastasis (2) 2
neoplasm staging (2) 2
neoplasms - drug therapy (2) 2
neoplasms - mortality (2) 2
oncology, experimental (2) 2
organoplatinum compounds - administration & dosage (2) 2
pegylated liposomal doxorubicin (2) 2
pharmacology & pharmacy (2) 2
phase-ii (2) 2
phase-ii trial (2) 2
radiation therapy (2) 2
refractory ovarian (2) 2
taxoids - administration & dosage (2) 2
trial (2) 2
tumors (2) 2
vascular endothelial growth factor (2) 2
13- cis -retinoic acid (1) 1
13-cis-ra (1) 1
2nd-look laparotomy (1) 1
active cancer (1) 1
active-drug (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - surgery (1) 1
adenocarcinoma - therapy (1) 1
adjuvant chemotherapy (1) 1
adjuvant therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 537 - 537
Journal Article
Cancer, ISSN 0008-543X, 02/2006, Volume 106, Issue 3, pp. 514 - 523
BACKGROUND The objective of the current study was a retrospective evaluation of 100 consecutive premenopausal women with high‐risk, early breast carcinoma who... 
ovarian protection | adjuvant therapy | gonadotropin‐releasing hormone analogue | high‐risk early breast carcinoma | High-risk early breast carcinoma | Ovarian protection | Gonadotropin-releasing hormone analogue | Adjuvant therapy | AMENORRHEA | CYCLOPHOSPHAMIDE | TAMOXIFEN | METHOTREXATE | FLUOROURACIL | PREMENOPAUSAL PATIENTS | CANCER | gonadotropin-releasing hormone analogue | TRIAL | high-risk early breast carcinoma | THERAPY | ONCOLOGY | GOSERELIN | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Estrogen Receptor Modulators | Gonadotropin-Releasing Hormone - analogs & derivatives | Fluorouracil - administration & dosage | Infertility, Female - chemically induced | Adult | Female | Ovary - drug effects | Gonadotropin-Releasing Hormone - therapeutic use | Retrospective Studies | Chemotherapy, Adjuvant | Carcinoma - pathology | Carcinoma - drug therapy | Premenopause | Ovary - physiology | Treatment Outcome | Breast Neoplasms - drug therapy | Pregnancy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Age of Onset | Infertility, Female - prevention & control | Methotrexate - administration & dosage | Pregnancy Outcome | Care and treatment | Gonadotropin releasing hormone | Patient outcomes | Physiological aspects | Breast cancer | Research | Ovaries
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 5/2007, Volume 56, Issue 5, pp. 699 - 708
Journal Article
Oncology Letters, ISSN 1792-1074, 04/2013, Volume 5, Issue 4, pp. 1117 - 1122
Estradiol (E2) plays a key role in human reproduction through the induction of vascular endothelial growth factor (VEGF) and T-regulatory cells (T-Regs), which... 
Chemotherapy | T-regulatory cells | Vascular endothelial growth factor | Premenopausal breast cancer | ADJUVANT CHEMOTHERAPY | SURVIVAL | FOXP3 EXPRESSION | RANDOMIZED-TRIALS | FACTOR RECEPTOR-1 | DOSE CARBOPLATIN | chemotherapy | PHASE | THERAPY | ONCOLOGY | vascular endothelial growth factor | premenopausal breast cancer | ESTROGEN | CARCINOMA
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 05/2006, Volume 26, Issue 3B, pp. 2317 - 2324
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2007, Volume 106, Issue 1, pp. 164 - 169
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 06/2007, Volume 18, Issue 5, pp. 597 - 604
Docetaxel, capecitabine and 5-fluorouracil have been shown to be active in the treatment of metastatic gastric adenocarcinoma. Consistent with this finding,... 
5-fluorouracil | Metastatic gastric cancer | Maintenance immunotherapy | Interleukin-2 | 13-cis-retinoic acid | Capecitabine | Docetaxel | Leucovorin | interleukin-2 | PHASE-II | RANDOMIZED-TRIAL | metastatic gastric cancer | MYELOID CELLS | RENAL-CELL CARCINOMA | MAINTENANCE THERAPY | CD4+/CD8+ RATIO | capecitabine | ONCOLOGY | docetaxel | maintenance immunotherapy | REGULATORY T-CELLS | PHARMACOLOGY & PHARMACY | leucovorin | HIGH-DOSE INTERLEUKIN-2 | 13-CIS RETINOIC ACID | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vascular Endothelial Growth Factor A - metabolism | Antidotes - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Antineoplastic Agents, Phytogenic - administration & dosage | CD4-CD8 Ratio | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Immunotherapy | Endpoint Determination | Aged, 80 and over | Killer Cells, Natural - immunology | Adult | Female | Neoplasm Metastasis - therapy | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Stomach Neoplasms - therapy | Combined Modality Therapy | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease Progression | Killer Cells, Natural - physiology | Taxoids - administration & dosage | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Survival Analysis | Lymphocyte Count | Aged | Stomach Neoplasms - surgery | Deoxycytidine - analogs & derivatives | Adenocarcinoma - surgery
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 01/2006, Volume 29, Issue 1, pp. 87 - 94
Journal Article
by Fuentes, HE and Tafur, AJ and Caprini, JA and Alatri, A and Trujillo-santos, J and Farge-bancel, D and Rosa, V and Font, L and Vilaseca, A and Monreal, M and Adarraga, MD and Aibar, MA and Aibar, J and Amado, C and Aranda, C and Arcelus, JI and Ballaz, A and Barba, R and Barillari, G and Barron, M and Barron-Andres, B and Bascunana, J and Benzidia, I and Bertoletti, L and Blanco-Molina, A and Bilora, F and Bortoluzzi, C and Bosevski, M and Bounameaux, H and Braester, A and Brandolin, B and Brenner, B and Bucherini, E and Bui, HM and Bura-Riviere, A and Camon, AM and Carrasco, C and Castro, J and Cesta, A and Ciammaichella, M and Cruz, JA and de Ancos, C and del Toro, J and Demelo, P and Dentali, F and Diaz-pedroche, MD and Diaz-Peromingo, JA and Di Micco, P and Di Pangrazio, M and Ellis, M and Encabo, M and Falga, C and Falvo, N and Farfan, AI and Fernandez-Capitan, C and Fidalgo, MA and Font, C and Fresa, M and Furest, I and Garcia, MA and Garcia-Braoado, F and Garcia-Morillo, M and Garcia-Raso, A and Gavin, O and Gil-Diaz, A and Gomez, V and Gomez-Cuervo, C and Gonzalez-Martinez, J and Grandone, E and Grau, E and Guijarro, R and Gutierrez, J and Gutierrez, P and Hernandez-Blasco, L and Hu, A and Hirmerova, J and Imbalzano, E and Jara-Palomares, L and Jaras, MJ and Jimenez, D and Jou, I and Joya, MD and Krstevski, G and Lessiani, G and Lima, J and Llamas, P and Lobo, JL and Lopez-Jimenez, L and Lopez-Miguel, P and Lopez-Nunez, JJ and Lopez-Reyes, R and Lopez-Saez, JB and Lorente, MA and Lorenzo, A and Loring, M and Lumbierres, M and Mahe, I and Maida, R and Maly, R and Manrique-Abos, I and ... and RIETE Investigators
INTERNATIONAL ANGIOLOGY, ISSN 0392-9590, 06/2019, Volume 38, Issue 3, pp. 173 - 184
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.